This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: 780 Effect of Breast Cancer Resistance Protein (BCRB) (C421A) Genetic Polymorphism on the Induction Response in the Treatment of Egyptian Pediatric Acute Lymphoblastic Leukemia, Children's Cancer Hospital Egypt-(CCHE)-57357 Experience, European Journal of Cancer, July 2012, Elsevier,
DOI: 10.1016/s0959-8049(12)71416-8.
You can read the full text:
The following have contributed to this page
